Global Drug and Gene Delivery System Market Growth (Status and Outlook) 2023-2029
The global Drug and Gene Delivery System market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Drug and Gene Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Drug and Gene Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Drug and Gene Delivery System is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Drug and Gene Delivery System players cover Pfizer, Johnson & Johnson, Novartis, Roche, Merck & Co., Sanofi, GlaxoSmithKline, AbbVie and AstraZeneca, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Drug and Gene Delivery System Industry Forecast” looks at past sales and reviews total world Drug and Gene Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug and Gene Delivery System sales for 2023 through 2029. With Drug and Gene Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug and Gene Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Drug and Gene Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug and Gene Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Drug and Gene Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug and Gene Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug and Gene Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug and Gene Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Drug Delivery System
Gene Delivery System
Segmentation by application
Diabetes
Central Nervous System
Infectious Disease
Oncology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer
Johnson & Johnson
Novartis
Roche
Merck & Co.
Sanofi
GlaxoSmithKline
AbbVie
AstraZeneca
Bayer
Bristol-MyersSquibb
Celgene
Amgen
Biogen
Gilead Sciences
Illumina
Regeneron Pharmaceuticals
Vertex Pharmaceuticals
Moderna
CRISPR Therapeutics
Please note: The report will take approximately 2 business days to prepare and deliver.
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Drug and Gene Delivery System Market Size 2018-2029
- 2.1.2 Drug and Gene Delivery System Market Size CAGR by Region 2018 VS 2022 VS 2029
- 2.2 Drug and Gene Delivery System Segment by Type
- 2.2.1 Drug Delivery System
- 2.2.2 Gene Delivery System
- 2.3 Drug and Gene Delivery System Market Size by Type
- 2.3.1 Drug and Gene Delivery System Market Size CAGR by Type (2018 VS 2022 VS 2029)
- 2.3.2 Global Drug and Gene Delivery System Market Size Market Share by Type (2018-2023)
- 2.4 Drug and Gene Delivery System Segment by Application
- 2.4.1 Diabetes
- 2.4.2 Central Nervous System
- 2.4.3 Infectious Disease
- 2.4.4 Oncology
- 2.4.5 Other
- 2.5 Drug and Gene Delivery System Market Size by Application
- 2.5.1 Drug and Gene Delivery System Market Size CAGR by Application (2018 VS 2022 VS 2029)
- 2.5.2 Global Drug and Gene Delivery System Market Size Market Share by Application (2018-2023)
- 3 Drug and Gene Delivery System Market Size by Player
- 3.1 Drug and Gene Delivery System Market Size Market Share by Players
- 3.1.1 Global Drug and Gene Delivery System Revenue by Players (2018-2023)
- 3.1.2 Global Drug and Gene Delivery System Revenue Market Share by Players (2018-2023)
- 3.2 Global Drug and Gene Delivery System Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
- 4 Drug and Gene Delivery System by Regions
- 4.1 Drug and Gene Delivery System Market Size by Regions (2018-2023)
- 4.2 Americas Drug and Gene Delivery System Market Size Growth (2018-2023)
- 4.3 APAC Drug and Gene Delivery System Market Size Growth (2018-2023)
- 4.4 Europe Drug and Gene Delivery System Market Size Growth (2018-2023)
- 4.5 Middle East & Africa Drug and Gene Delivery System Market Size Growth (2018-2023)
- 5 Americas
- 5.1 Americas Drug and Gene Delivery System Market Size by Country (2018-2023)
- 5.2 Americas Drug and Gene Delivery System Market Size by Type (2018-2023)
- 5.3 Americas Drug and Gene Delivery System Market Size by Application (2018-2023)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Drug and Gene Delivery System Market Size by Region (2018-2023)
- 6.2 APAC Drug and Gene Delivery System Market Size by Type (2018-2023)
- 6.3 APAC Drug and Gene Delivery System Market Size by Application (2018-2023)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 7 Europe
- 7.1 Europe Drug and Gene Delivery System by Country (2018-2023)
- 7.2 Europe Drug and Gene Delivery System Market Size by Type (2018-2023)
- 7.3 Europe Drug and Gene Delivery System Market Size by Application (2018-2023)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Drug and Gene Delivery System by Region (2018-2023)
- 8.2 Middle East & Africa Drug and Gene Delivery System Market Size by Type (2018-2023)
- 8.3 Middle East & Africa Drug and Gene Delivery System Market Size by Application (2018-2023)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Global Drug and Gene Delivery System Market Forecast
- 10.1 Global Drug and Gene Delivery System Forecast by Regions (2024-2029)
- 10.1.1 Global Drug and Gene Delivery System Forecast by Regions (2024-2029)
- 10.1.2 Americas Drug and Gene Delivery System Forecast
- 10.1.3 APAC Drug and Gene Delivery System Forecast
- 10.1.4 Europe Drug and Gene Delivery System Forecast
- 10.1.5 Middle East & Africa Drug and Gene Delivery System Forecast
- 10.2 Americas Drug and Gene Delivery System Forecast by Country (2024-2029)
- 10.2.1 United States Drug and Gene Delivery System Market Forecast
- 10.2.2 Canada Drug and Gene Delivery System Market Forecast
- 10.2.3 Mexico Drug and Gene Delivery System Market Forecast
- 10.2.4 Brazil Drug and Gene Delivery System Market Forecast
- 10.3 APAC Drug and Gene Delivery System Forecast by Region (2024-2029)
- 10.3.1 China Drug and Gene Delivery System Market Forecast
- 10.3.2 Japan Drug and Gene Delivery System Market Forecast
- 10.3.3 Korea Drug and Gene Delivery System Market Forecast
- 10.3.4 Southeast Asia Drug and Gene Delivery System Market Forecast
- 10.3.5 India Drug and Gene Delivery System Market Forecast
- 10.3.6 Australia Drug and Gene Delivery System Market Forecast
- 10.4 Europe Drug and Gene Delivery System Forecast by Country (2024-2029)
- 10.4.1 Germany Drug and Gene Delivery System Market Forecast
- 10.4.2 France Drug and Gene Delivery System Market Forecast
- 10.4.3 UK Drug and Gene Delivery System Market Forecast
- 10.4.4 Italy Drug and Gene Delivery System Market Forecast
- 10.4.5 Russia Drug and Gene Delivery System Market Forecast
- 10.5 Middle East & Africa Drug and Gene Delivery System Forecast by Region (2024-2029)
- 10.5.1 Egypt Drug and Gene Delivery System Market Forecast
- 10.5.2 South Africa Drug and Gene Delivery System Market Forecast
- 10.5.3 Israel Drug and Gene Delivery System Market Forecast
- 10.5.4 Turkey Drug and Gene Delivery System Market Forecast
- 10.5.5 GCC Countries Drug and Gene Delivery System Market Forecast
- 10.6 Global Drug and Gene Delivery System Forecast by Type (2024-2029)
- 10.7 Global Drug and Gene Delivery System Forecast by Application (2024-2029)
- 11 Key Players Analysis
- 11.1 Pfizer
- 11.1.1 Pfizer Company Information
- 11.1.2 Pfizer Drug and Gene Delivery System Product Offered
- 11.1.3 Pfizer Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.1.4 Pfizer Main Business Overview
- 11.1.5 Pfizer Latest Developments
- 11.2 Johnson & Johnson
- 11.2.1 Johnson & Johnson Company Information
- 11.2.2 Johnson & Johnson Drug and Gene Delivery System Product Offered
- 11.2.3 Johnson & Johnson Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.2.4 Johnson & Johnson Main Business Overview
- 11.2.5 Johnson & Johnson Latest Developments
- 11.3 Novartis
- 11.3.1 Novartis Company Information
- 11.3.2 Novartis Drug and Gene Delivery System Product Offered
- 11.3.3 Novartis Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.3.4 Novartis Main Business Overview
- 11.3.5 Novartis Latest Developments
- 11.4 Roche
- 11.4.1 Roche Company Information
- 11.4.2 Roche Drug and Gene Delivery System Product Offered
- 11.4.3 Roche Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.4.4 Roche Main Business Overview
- 11.4.5 Roche Latest Developments
- 11.5 Merck & Co.
- 11.5.1 Merck & Co. Company Information
- 11.5.2 Merck & Co. Drug and Gene Delivery System Product Offered
- 11.5.3 Merck & Co. Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.5.4 Merck & Co. Main Business Overview
- 11.5.5 Merck & Co. Latest Developments
- 11.6 Sanofi
- 11.6.1 Sanofi Company Information
- 11.6.2 Sanofi Drug and Gene Delivery System Product Offered
- 11.6.3 Sanofi Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.6.4 Sanofi Main Business Overview
- 11.6.5 Sanofi Latest Developments
- 11.7 GlaxoSmithKline
- 11.7.1 GlaxoSmithKline Company Information
- 11.7.2 GlaxoSmithKline Drug and Gene Delivery System Product Offered
- 11.7.3 GlaxoSmithKline Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.7.4 GlaxoSmithKline Main Business Overview
- 11.7.5 GlaxoSmithKline Latest Developments
- 11.8 AbbVie
- 11.8.1 AbbVie Company Information
- 11.8.2 AbbVie Drug and Gene Delivery System Product Offered
- 11.8.3 AbbVie Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.8.4 AbbVie Main Business Overview
- 11.8.5 AbbVie Latest Developments
- 11.9 AstraZeneca
- 11.9.1 AstraZeneca Company Information
- 11.9.2 AstraZeneca Drug and Gene Delivery System Product Offered
- 11.9.3 AstraZeneca Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.9.4 AstraZeneca Main Business Overview
- 11.9.5 AstraZeneca Latest Developments
- 11.10 Bayer
- 11.10.1 Bayer Company Information
- 11.10.2 Bayer Drug and Gene Delivery System Product Offered
- 11.10.3 Bayer Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.10.4 Bayer Main Business Overview
- 11.10.5 Bayer Latest Developments
- 11.11 Bristol-MyersSquibb
- 11.11.1 Bristol-MyersSquibb Company Information
- 11.11.2 Bristol-MyersSquibb Drug and Gene Delivery System Product Offered
- 11.11.3 Bristol-MyersSquibb Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.11.4 Bristol-MyersSquibb Main Business Overview
- 11.11.5 Bristol-MyersSquibb Latest Developments
- 11.12 Celgene
- 11.12.1 Celgene Company Information
- 11.12.2 Celgene Drug and Gene Delivery System Product Offered
- 11.12.3 Celgene Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.12.4 Celgene Main Business Overview
- 11.12.5 Celgene Latest Developments
- 11.13 Amgen
- 11.13.1 Amgen Company Information
- 11.13.2 Amgen Drug and Gene Delivery System Product Offered
- 11.13.3 Amgen Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.13.4 Amgen Main Business Overview
- 11.13.5 Amgen Latest Developments
- 11.14 Biogen
- 11.14.1 Biogen Company Information
- 11.14.2 Biogen Drug and Gene Delivery System Product Offered
- 11.14.3 Biogen Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.14.4 Biogen Main Business Overview
- 11.14.5 Biogen Latest Developments
- 11.15 Gilead Sciences
- 11.15.1 Gilead Sciences Company Information
- 11.15.2 Gilead Sciences Drug and Gene Delivery System Product Offered
- 11.15.3 Gilead Sciences Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.15.4 Gilead Sciences Main Business Overview
- 11.15.5 Gilead Sciences Latest Developments
- 11.16 Illumina
- 11.16.1 Illumina Company Information
- 11.16.2 Illumina Drug and Gene Delivery System Product Offered
- 11.16.3 Illumina Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.16.4 Illumina Main Business Overview
- 11.16.5 Illumina Latest Developments
- 11.17 Regeneron Pharmaceuticals
- 11.17.1 Regeneron Pharmaceuticals Company Information
- 11.17.2 Regeneron Pharmaceuticals Drug and Gene Delivery System Product Offered
- 11.17.3 Regeneron Pharmaceuticals Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.17.4 Regeneron Pharmaceuticals Main Business Overview
- 11.17.5 Regeneron Pharmaceuticals Latest Developments
- 11.18 Vertex Pharmaceuticals
- 11.18.1 Vertex Pharmaceuticals Company Information
- 11.18.2 Vertex Pharmaceuticals Drug and Gene Delivery System Product Offered
- 11.18.3 Vertex Pharmaceuticals Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.18.4 Vertex Pharmaceuticals Main Business Overview
- 11.18.5 Vertex Pharmaceuticals Latest Developments
- 11.19 Moderna
- 11.19.1 Moderna Company Information
- 11.19.2 Moderna Drug and Gene Delivery System Product Offered
- 11.19.3 Moderna Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.19.4 Moderna Main Business Overview
- 11.19.5 Moderna Latest Developments
- 11.20 CRISPR Therapeutics
- 11.20.1 CRISPR Therapeutics Company Information
- 11.20.2 CRISPR Therapeutics Drug and Gene Delivery System Product Offered
- 11.20.3 CRISPR Therapeutics Drug and Gene Delivery System Revenue, Gross Margin and Market Share (2018-2023)
- 11.20.4 CRISPR Therapeutics Main Business Overview
- 11.20.5 CRISPR Therapeutics Latest Developments
- 12 Research Findings and Conclusion
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook